RAHUL DAVE DHIMAN

Allopathic & Osteopathic Physicians|Internal Medicine PHILADELPHIA, PA NPI 1780171066

General Payments — all program years on this page

$576.87

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 25
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $532.71 across 24 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $532.7124

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $44.161
2024 $532.7124

Records — PY2024 (24)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1075850565 Celltrion USA Inc. $16.72 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078584754 Janssen Biotech, Inc. $18.98 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078586619 Janssen Biotech, Inc. $19.69 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078586708 Janssen Biotech, Inc. $19.44 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078589083 Janssen Biotech, Inc. $18.87 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092323167 Boston Scientific Corporation $149.53 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101128330 Celgene Corporation $18.62 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103636060 ABBVIE INC. $11.46 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103636062 ABBVIE INC. $16.13 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103636064 ABBVIE INC. $12.30 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103636066 ABBVIE INC. $15.21 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103636068 ABBVIE INC. $5.35 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103636070 ABBVIE INC. $13.00 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103636072 ABBVIE INC. $18.99 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103636074 ABBVIE INC. $19.67 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103636076 ABBVIE INC. $17.03 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103636078 ABBVIE INC. $15.90 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131549804 PFIZER INC. $16.67 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131552620 PFIZER INC. $15.08 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131561934 PFIZER INC. $16.98 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137530360 Takeda Pharmaceuticals U.S.A., Inc. $19.46 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139763480 GENZYME CORPORATION $21.53 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139763496 GENZYME CORPORATION $20.39 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146678174 Ardelyx, Inc. $15.71 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.